Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 8/20 | 0.54 |
| ▸ | NTSR1 | P30989 | 3/20 | 0.53 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.50 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.49 |
| ▸ | F2 | P00734 | 3/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29800893 | 0.95 | NTSR1 (0.54) | OPRD1NTSR1OPRM1NTSR2F2 | |
| SCHEMBL30918791 | 0.92 | OPRD1 (0.55) | OPRD1OPRM1F2 | |
| SCHEMBL31067241 | 0.91 | NTSR1 (0.55) | OPRD1NTSR1OPRM1NTSR2F2 | |
| SCHEMBL31067238 | 0.89 | NTSR1 (0.50) | OPRD1NTSR1NTSR2F2 | |
| SCHEMBL29800522 | 0.89 | CXCR4 (0.51) | NTSR1NTSR2 | |
| SCHEMBL29569246 | 0.89 | NTSR1 (0.44) | OPRD1NTSR1NTSR2F2 | |
| SCHEMBL31191392 | 0.88 | OPRD1 (0.52) | OPRD1NTSR1OPRM1NTSR2 | |
| SCHEMBL29904119 | 0.87 | MAGI3 (0.52) | NTSR1 | |
| SCHEMBL31226869 | 0.87 | NTSR1 (0.60) | OPRD1NTSR1NTSR2F2 | |
| SCHEMBL29800900 | 0.87 | NTSR1 (0.48) | OPRD1NTSR1NTSR2F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240287147-A1 | PD-L1 BINDING PEPTIDES AND PEPTIDE COMPLEXES AND METHODS OF USE THEREOF | Blaze Bioscience, Inc. | 2024-08-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240287147-A1 | PD-L1 BINDING PEPTIDES AND PEPTIDE COMPLEXES AND METHODS OF USE THEREOF | PDCD1LG2, CD274, PDCD1 | OPRD1 1859/4885NTSR1 258/4885OPRM1 2099/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.